tiprankstipranks
Ultragenyx Pharmaceutical (RARE)
NASDAQ:RARE
US Market
RARE
Ultragenyx Pharmaceutical
RESEARCH TOOLSreports
Want to see RARE full AI Analyst Report?

Ultragenyx Pharmaceutical (RARE) Balance Sheet

1,297 Followers

Ultragenyx Pharmaceutical Balance Sheet

Ultragenyx Pharmaceutical's total assets for Q2 2026 were $1.26B, a decrease of -2.47% from the previous quarter. RARE total liabilities were $1.55B for the fiscal quarter, a 1.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 1.53B$ 1.50B$ 1.49B$ 1.55B$ 1.52B
Total Liabilities
$ 1.60B$ 1.24B$ 1.22B$ 1.19B$ 599.84M
Total Equity Gross Minority
$ -73.00M$ 262.30M$ 275.41M$ 352.49M$ 922.56M
Other Metrics
Currency in USD

Ultragenyx Pharmaceutical Debt to Assets